Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
PNTG Stock Forecast 2026-2027
$39.86
Current Price
$1.39B
Market Cap
Buy 7
Hold 0
Sell 0
Wall St Analyst Ratings
Distance to PNTG Price Targets
+15.4%
To High Target of $46.00
+4.1%
To Median Target of $41.50
+0.4%
To Low Target of $40.00
PNTG Price Momentum
+0.4%
1 Week Change
+21.3%
1 Month Change
+57.2%
1 Year Change
+41.6%
Year-to-Date Change
-4.3%
From 52W High of $41.67
+83.4%
From 52W Low of $21.73
📊 TOP ANALYST CALLS
Did PNTG Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Pennant Group is one of their latest high-conviction picks.
Latest PNTG Stock Price Targets & Analyst Predictions
Based on our analysis of 4 Wall Street analysts, PNTG has a bullish consensus with a median price target of $41.50 (ranging from $40.00 to $46.00). The overall analyst rating is Strong Buy (9.7/10). Currently trading at $39.86, the median forecast implies a 4.1% upside. This outlook is supported by 7 Buy, 0 Hold, and 0 Sell ratings.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
PNTG Analyst Ratings
7
Buy
0
Hold
0
Sell
PNTG Price Target Range
Low
$40.00
Average
$41.50
High
$46.00
Current: $39.86
Latest PNTG Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for PNTG.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| May 8, 2026 | RBC Capital | Ben Hendrix | Outperform | Maintains | $42.00 |
| May 8, 2026 | Truist Securities | David Macdonald | Buy | Maintains | $42.00 |
| May 8, 2026 | Wells Fargo | Stephen Baxter | Overweight | Maintains | $41.00 |
| Apr 13, 2026 | Truist Securities | Buy | Maintains | $N/A | |
| Mar 2, 2026 | RBC Capital | Outperform | Maintains | $N/A | |
| Jan 7, 2026 | Wells Fargo | Overweight | Maintains | $N/A | |
| Dec 8, 2025 | William Blair | Outperform | Initiates | $N/A | |
| Dec 2, 2025 | Truist Securities | Buy | Upgrade | $N/A | |
| Nov 18, 2025 | Wells Fargo | Overweight | Upgrade | $N/A | |
| Nov 17, 2025 | RBC Capital | Outperform | Maintains | $N/A | |
| Oct 24, 2025 | Jefferies | Buy | Initiates | $N/A | |
| Oct 9, 2025 | Stephens & Co. | Overweight | Reiterates | $N/A | |
| Sep 4, 2025 | Stephens & Co. | Overweight | Reiterates | $N/A | |
| Aug 14, 2025 | Wells Fargo | Equal-Weight | Maintains | $N/A | |
| Jul 16, 2025 | Truist Securities | Hold | Maintains | $N/A | |
| Jun 10, 2025 | Stephens & Co. | Overweight | Reiterates | $N/A | |
| Jun 3, 2025 | Wells Fargo | Equal-Weight | Maintains | $N/A | |
| May 12, 2025 | Truist Securities | Hold | Maintains | $N/A | |
| Apr 2, 2025 | Stephens & Co. | Overweight | Reiterates | $N/A | |
| Mar 11, 2025 | Stephens & Co. | Overweight | Reiterates | $N/A |
The Pennant Group, Inc. (PNTG) Competitors
The following stocks are similar to Pennant Group based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
PNTG
Pennant Group
mkt cap
1.41B
The Pennant Group, Inc. (PNTG) Financial Data
The Pennant Group, Inc. has a market capitalization of $1.39B with a P/E ratio of 47.1x. The company generates $1.02B in trailing twelve-month revenue with a 3.0% profit margin.
Revenue growth is +36.0% quarter-over-quarter, while maintaining an operating margin of +5.9% and return on equity of +10.0%.
Valuation Metrics
Market Cap
$1.39B
Enterprise Value
$1.90B
P/E Ratio
47.1x
PEG Ratio
5.4x
Price/Sales
1.4x
Growth & Margins
Revenue Growth (YoY)
+36.0%
Gross Margin
+13.9%
Operating Margin
+5.9%
Net Margin
+3.0%
EPS Growth
+9.6%
Financial Health
Cash/Price Ratio
+0.4%
Current Ratio
1.2x
Debt/Equity
116.6x
ROE
+10.0%
ROA
+4.1%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
The Pennant Group, Inc. (PNTG) Business Model
About The Pennant Group, Inc.
What They Do
Provides post-acute healthcare services in the U.S.
Business Model
The company operates home health and hospice agencies, as well as senior living communities, generating revenue through skilled nursing and housing services tailored to elderly populations. Its decentralized service model empowers local leadership, allowing for customized care that meets the specific needs of each community.
Additional Information
Pennant Group, Inc. plays a significant role in the continuum of care for aging demographics and is positioned to benefit from the growing demand for senior care services. Its focus on home-based care solutions aligns with industry trends towards personalized healthcare delivery, making it an attractive investment in the evolving healthcare landscape.
Company Information
Sector
Healthcare
Industry
Medical Care Facilities
Employees
9,700
CEO
Mr. Brent J. Guerisoli
Country
United States
IPO Year
N/A
Website
pennantgroup.comThe Pennant Group, Inc. (PNTG) Latest News & Analysis
Latest News
Quick Summary
The Pennant Group (PNTG) has reached a 52-week high, prompting an assessment of its fundamentals to evaluate potential for future gains.
Why It Matters
PNTG reaching a 52-week high signals strong performance, but analyzing fundamentals is crucial to assess potential for further gains and informed investment decisions.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
DVA is expanding its kidney care services with outpatient, home-centered, and value-based programs, alongside investments in AI-enabled scheduling technology.
Why It Matters
DVA's expansion into kidney care and AI scheduling indicates growth potential and innovation, likely enhancing efficiency and profitability, which can positively impact stock performance.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
The Pennant Group, Inc. (NASDAQ: PNTG) has assumed operations of Memory Care of Contra Costa, its first senior living expansion in California since becoming independent in 2019.
Why It Matters
Pennant Group's expansion into California signals potential growth and increased market presence, which could enhance revenue and investor confidence in the company's future performance.
Source: GlobeNewsWire
Market Sentiment:
Neutral
The Pennant Group and Hartford HealthCare Expand Collaboration to Advance Home-Based Care in Connecticut
1 month ago
Quick Summary
The Pennant Group (NASDAQ: PNTG) and Hartford HealthCare have announced an expanded collaboration to enhance home-based care services in Connecticut.
Why It Matters
The collaboration between Pennant Group and Hartford HealthCare signals potential growth in home-based care services, which could enhance revenue and market position, attracting investor interest.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Wall Street Analysts Believe The Pennant Group (PNTG) Could Rally 27.59%: Here's is How to Trade
1 month ago
Quick Summary
Wall Street analysts predict a 27.6% upside for The Pennant Group (PNTG), supported by positive earnings estimate revisions.
Why It Matters
The 27.6% upside in price targets for The Pennant Group (PNTG) suggests strong potential growth, bolstered by positive earnings revisions, indicating favorable market sentiment.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
The Pennant Group (PNTG) has strong growth attributes that may lead to superior market performance.
Why It Matters
The Pennant Group's strong growth potential may lead to superior market performance, indicating potential for higher returns on investments.
Source: Zacks Investment Research
Market Sentiment:
Positive
Frequently Asked Questions About PNTG Stock
What is The Pennant Group, Inc.'s (PNTG) stock forecast for 2027?
Based on our analysis of 4 Wall Street analysts, The Pennant Group, Inc. (PNTG) has a median price target of $41.50. The highest price target is $46.00 and the lowest is $40.00.
Is PNTG stock a good investment in 2027?
According to current analyst ratings, PNTG has 7 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $39.86. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for PNTG stock?
Wall Street analysts predict PNTG stock could reach $41.50 in the next 12 months. This represents a 4.1% increase from the current price of $39.86. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is The Pennant Group, Inc.'s business model?
The company operates home health and hospice agencies, as well as senior living communities, generating revenue through skilled nursing and housing services tailored to elderly populations. Its decentralized service model empowers local leadership, allowing for customized care that meets the specific needs of each community.
What is the highest forecasted price for PNTG The Pennant Group, Inc.?
The highest price target for PNTG is $46.00 from at , which represents a 15.4% increase from the current price of $39.86.
What is the lowest forecasted price for PNTG The Pennant Group, Inc.?
The lowest price target for PNTG is $40.00 from at , which represents a 0.4% increase from the current price of $39.86.
What is the overall PNTG consensus from analysts for The Pennant Group, Inc.?
The overall analyst consensus for PNTG is bullish. Out of 4 Wall Street analysts, 7 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $41.50.
How accurate are PNTG stock price projections?
Stock price projections, including those for The Pennant Group, Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: July 14, 2026 2:20 PM UTC